Marta Hernández-Díaz

Marta Hernández-Díaz

Auto-generated profile, based on publicly available information

Marta Hernández-Díaz

Servicio de Reumatología, Hospital Universitario de Canarias, La Laguna, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2024 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
MHMarta Hernández-Díaz
Marta Hernández-Díaz
DGDara Rodríguez González
Dara Rodríguez González
EHElena Heras-Recuero
Elena Heras-Recuero
FGFuensanta Gómez
Fuensanta Gómez
JQJuan Carlos Quevedo-Abeledo
Juan Carlos Quevedo-Abeledo
IFIván Ferraz-Amaro
Iván Ferraz-Amaro
Background: Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular (CV) events and CV mortality. Subclinical carotid atherosclerosis is independently associated with rates of incident CV events among patients with RA. The complement system has been related to both the etiopathogenesis of RA and CV disease. In this study, we aimed to evaluate the association between a comprehensive assessment of the complement system and carotid intima media thickness and carotid plaque in patients with RA. Methods: 430 patients with RA were recruited. Functional assays of the three pathways of the complement system, utilizing new-generation techniques, were assessed. Additionally, serum levels of individual components of the complement system belonging to the three pathways were measured: C1q (classical), lectin (lectin), C2, C4, and C4b (classical and lectin), factor D and properdin (alternative), C3 and C3a (common), C5, C5a, and C9 (terminal), as well as regulators factor I and C1-inhibitor. Subclinical carotid atherosclerosis was evaluated by ultrasonography. Multivariable linear regression analysis was conducted to investigate the association between the complement system and carotid intima media thickness and carotid plaque. Results: After multivariable adjustment, which included traditional CV risk factors and disease-related data, C3a and C5a exhibited significant positive correlations with carotid intima media thickness. Additionally, higher values of C1-inhibitor, properdin, C3, C5, and C5a were independently associated with the presence of carotid plaque. Conclusion: The complement system and subclinical carotid atherosclerosis are linked in patients with RA.

17 November 2025 in Rheumatology
Verified
Journal Article
Closed access
IFIván Ferraz-Amaro
Iván Ferraz-Amaro
MHMarta Hernández-Díaz
Marta Hernández-Díaz
JGJosé Carlos García-Hernández
José Carlos García-Hernández
AVAna Isabel Rodríguez Vargas
Ana Isabel Rodríguez Vargas
MRMónica Renuncio-García
Mónica Renuncio-García
FDFederico Diaz-Gonzalez
Federico Diaz-Gonzalez
Objectives: The effects of systemic tumour necrosis factor (TNF) inhibition on glucose homeostasis are not fully understood. This study aims to evaluate the effects of TNF inhibitors (TNFis) on gastric inhibitory polypeptide (GIP), amylin and pancreatic polypeptide (PP), hormones involved in the fine-tuning of postprandial glucose homeostasis, in patients with RA, PsA and axial spondylarthritis (axSpA). Methods: Sixty-four non-diabetic patients (RA, n = 22; PsA, n = 13; axSpA, n = 29) undergoing TNFi therapy were prospectively evaluated at baseline and after 12, 24 and 52 weeks. Assessments included measurements of disease activity, acute-phase reactants, fasting glucose, insulin and C-peptide levels, insulin resistance as assessed by the updated Homeostatic Model Assessment (HOMA)2 and lipid profile. Serum concentrations of amylin, GIP and PP were measured at each visit. Multivariable linear mixed-effects models were used to analyse temporal changes in clinical and biochemical variables. Results: Basal insulin resistance indices did not significantly change throughout the study in patients with RA, PsA or axSpA. However, serum basal levels of GIP, amylin and PP significantly increased in the univariable model, and the results remained consistent after adjusting for CRP, at 12, 24 and 52 weeks of TNFi therapy. These effects were consistent and specific across different TNFi types and diagnoses, except for PP, which exhibited a significant interaction with the type of arthritis. Conclusions: In patients initiating TNFi therapy, serum levels of GIP, amylin and PP increase regardless of systemic inflammation. This effect on postprandial glucose-regulating hormones may help explain the cardiovascular benefits of TNFi in rheumatic inflammatory diseases, at least in part.

18 August 2026 in International Journal of Health Policy and Management
Verified
Journal Article
Open access
PDF file
AAAntonio Jenaro Aznar-Esquivel
Antonio Jenaro Aznar-Esquivel
MHMarta Hernández-Díaz
Marta Hernández-Díaz
IFIván Ferraz-Amaro
Iván Ferraz-Amaro
MFMiguel Flores-Rodríguez
Miguel Flores-Rodríguez
JVJose María Viotti
Jose María Viotti
FDFederico Diaz-Gonzalez
Federico Diaz-Gonzalez
Background: Rising demand for rheumatology care strains referral pathways between primary care and specialist services. We evaluated whether a virtual interconsultation (VIC) program, an asynchronous e-consult system integrated into the electronic health record (EHR), improved referral efficiency for new patients and generated net societal cost savings in a public health system. Methods: We conducted a retrospective study of 12 213 VICs (10 181 patients) submitted from primary care to a tertiary rheumatology service between January 2021 and June 2022. Extracted EHR data included demographics, referral reason, delay time (submission to specialist response), resolution time (minutes per case), and outcomes (virtual resolution vs. in-person referral). Referral efficiency was assessed by the proportion of referrals resolved without an in-person visit and time to specialist response. Descriptive and comparative analyses used Mann–Whitney U, chi-square, and student’s t tests. The economic evaluation used a cost-avoidance micro costing approach from a societal perspective. Robustness of the economic evaluation was assessed through one-way sensitivity analyses, probabilistic Monte Carlo simulations (>100 000 iterations), and threshold analysis (ie, the minimum virtual resolution rate at which the program achieves breakeven). Results: Patients were predominantly female (69%), mean age 54.8 years. Median specialist response time was 53.5 hours (interquartile range [IQR]: 20.6–122.3) and median resolution time 3.2 minutes (IQR: 1.6–8.6). Overall, 41.4% of referrals were resolved without an in-person visit. The program generated net societal savings of €206 280 over 18 months in the deterministic base case; the probabilistic analysis yielded a mean of €200 540 (95% credible interval: €142 289–€261 316) and a 100% probability of net savings. Absenteeism was the principal economic driver (highest Spearman correlation with net savings in Monte Carlo simulation, r=0.92). The breakeven virtual resolution rate was 5.6%. Conclusion: Integrating VICs into routine rheumatology referral pathways improved referral efficiency and produced substantial societal cost savings. These findings support scaling EHR-integrated VIC programs across publicly funded health systems to optimize specialist resources and enhance access to care.